{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T11:59:00Z","timestamp":1764331140237},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,27]]},"DOI":"10.7759\/cureus.29660","type":"journal-article","created":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T19:15:46Z","timestamp":1664306146000},"source":"Crossref","is-referenced-by-count":9,"title":["A Case Series on the COVID-19 Vaccines and Possible Immune-Related Adverse Events: A New Challenge for the Rheumatologists"],"prefix":"10.7759","author":[{"given":"Vicky","family":"Nahra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahesha","family":"Makandura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maya","family":"Mattar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald D","family":"Anthony","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S315727","article-title":"Overview of the main anti-SARS-CoV-2 vaccines: mechanism of action, efficacy and safety","volume":"14","author":"Mascellino MT","year":"2021","unstructured":"Mascellino MT, Di Timoteo F, De Angelis M, Oliva A. Overview of the main anti-SARS-CoV-2 vaccines: mechanism of action, efficacy and safety. Infect Drug Resist. 2021, 14:3459-76. 10.2147\/IDR.S315727","journal-title":"Infect Drug Resist"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(21)00067-9","article-title":"Arthritis after SARS-CoV-2 infection","volume":"3","author":"Baimukhamedov C","year":"2021","unstructured":"Baimukhamedov C, Barskova T, Matucci-Cerinic M. Arthritis after SARS-CoV-2 infection. Lancet Rheumatol. 2021, 3:e324-5. 10.1016\/S2665-9913(21)00067-9","journal-title":"Lancet Rheumatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/art.41417","article-title":"Rheumatoid arthritis pathogenesis, prediction, and prevention: an emerging paradigm shift","volume":"73","author":"Deane KD","year":"2021","unstructured":"Deane KD, Holers VM. Rheumatoid arthritis pathogenesis, prediction, and prevention: an emerging paradigm shift. Arthritis Rheumatol. 2021, 73:181-93. 10.1002\/art.41417","journal-title":"Arthritis Rheumatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2018-000694","article-title":"Polymyalgia rheumatica: an autoinflammatory disorder?","volume":"4","author":"Floris A","year":"2018","unstructured":"Floris A, Piga M, Cauli A, Salvarani C, Mathieu A. Polymyalgia rheumatica: an autoinflammatory disorder?. RMD Open. 2018, 4:e000694. 10.1136\/rmdopen-2018-000694","journal-title":"RMD Open"},{"key":"ref5","article-title":"Polymyalgia Rheumatica","author":"Acharya S","year":"2021","unstructured":"Acharya S, Musa R. Polymyalgia Rheumatica. StatPearls Publishing, Treasure Island, FL; 2021."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00578-z","article-title":"Immunological mechanisms of vaccine-induced protection against COVID-19 in humans","volume":"21","author":"Sadarangani M","year":"2021","unstructured":"Sadarangani M, Marchant A, Kollmann TR. Immunological mechanisms of vaccine-induced protection against COVID-19 in humans. Nat Rev Immunol. 2021, 21:475-84. 10.1038\/s41577-021-00578-z","journal-title":"Nat Rev Immunol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102732","article-title":"Giant cell arteritis or polymyalgia rheumatica after influenza vaccination: a study of 12 patients and a literature review","volume":"20","author":"Liozon E","year":"2021","unstructured":"Liozon E, Parreau S, Filloux M, et al.. Giant cell arteritis or polymyalgia rheumatica after influenza vaccination: a study of 12 patients and a literature review. Autoimmun Rev. 2021, 20:102732. 10.1016\/j.autrev.2020.102732","journal-title":"Autoimmun Rev"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2019.03.007","article-title":"Autoimmune\/inflammatory syndrome induced by adjuvants (ASIA) demonstrates distinct autoimmune and autoinflammatory disease associations according to the adjuvant subtype: insights from an analysis of 500 cases","volume":"203","author":"Watad A","year":"2019","unstructured":"Watad A, Bragazzi NL, McGonagle D, et al.. Autoimmune\/inflammatory syndrome induced by adjuvants (ASIA) demonstrates distinct autoimmune and autoinflammatory disease associations according to the adjuvant subtype: insights from an analysis of 500 cases. Clin Immunol. 2019, 203:1-8. 10.1016\/j.clim.2019.03.007","journal-title":"Clin Immunol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.589833","article-title":"Adjuvants for coronavirus vaccines","volume":"11","author":"Liang Z","year":"2020","unstructured":"Liang Z, Zhu H, Wang X, et al.. Adjuvants for coronavirus vaccines. Front Immunol. 2020, 11:589833. 10.3389\/fimmu.2020.589833","journal-title":"Front Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.31138\/mjr.28.2.64","article-title":"The ASIA syndrome: basic concepts","volume":"28","author":"Watad A","year":"2017","unstructured":"Watad A, Sharif K, Shoenfeld Y. The ASIA syndrome: basic concepts. Mediterr J Rheumatol. 2017, 28:64-9. 10.31138\/mjr.28.2.64","journal-title":"Mediterr J Rheumatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/agm2.12171","article-title":"Polymyalgia rheumatica as uncommon adverse event following immunization with COVID-19 vaccine: a case report and review of literature","volume":"4","author":"Manzo C","year":"2021","unstructured":"Manzo C, Natale M, Castagna A. Polymyalgia rheumatica as uncommon adverse event following immunization with COVID-19 vaccine: a case report and review of literature. Aging Med (Milton). 2021, 4:234-8. 10.1002\/agm2.12171","journal-title":"Aging Med (Milton)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9050435","article-title":"Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA\/DNA SARS-CoV-2 vaccination","volume":"9","author":"Watad A","year":"2021","unstructured":"Watad A, De Marco G, Mahajna H, et al.. Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA\/DNA SARS-CoV-2 vaccination. Vaccines (Basel). 2021, 9:435. 10.3390\/vaccines9050435","journal-title":"Vaccines (Basel)"},{"key":"ref13","unstructured":"COVID-19 vaccination experience in patients with rheumatoid arthritis treated at the Cleveland VA medical center. (2021). Accessed. November 20, 2021: https:\/\/acrabstracts.org\/abstract\/covid-19-vaccination-experience-in-patients-with-rheumatoid-arthritis-treated-at-th...."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/115335-a-case-series-on-the-covid-19-vaccines-and-possible-immune-related-adverse-events-a-new-challenge-for-the-rheumatologists","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:48:53Z","timestamp":1707508133000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/115335-a-case-series-on-the-covid-19-vaccines-and-possible-immune-related-adverse-events-a-new-challenge-for-the-rheumatologists"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,27]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.29660","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,27]]}}}